Barricaid is one of the most studied devices in spine

Proven superior to discectomy alone.

LEARN MORE

Proven to reduce the risk of reoperation for reherniation by

The Barricaid implant was rigorously tested in multiple clinical studies and approved for us by the U.S. Food and Drug Administration (FDA) through the PMA process which is the gold standard for measuring safety. Barricaid has been implanted in over 11,000 patients with follow-up durations as long as 10+ years.

81%

*Some studies outside U.S. indications. Values at Minimum 1 year PostOp. Minimum study size of 20 Barricaid subjects.

8 Study Populations

Average 81% Reduction in Reoperation to Treat Reherniations
Patients who undergo a second surgery see worse results.

The burden of repeat surgery.

44%

Patients not satisfied with outcome

88%

Using opiods at higher doses

68%

Not working

Repeat surgery can be devastating.

LAURA - PATIENT

MARIA – PATIENT

By closing the hole with Barricaid, repeat surgery can be avoided.

DR. BRUGGEMAN - SURGEON

GOAL:

Make Your
First Surgery,
Your Last

Want to
Learn More?

VISIT FAQS

Want to
Learn More?

VISIT FAQS

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin